Diagnostic Scientific Posters
Development of Inactivated Influenza Controls Optimized for Use With Antigen-Based Assays
Explore how ZeptoMetrix employed a novel irradiation method to inactivate Influenza virus while preserving protein integrity, resulting in the successful development of PROtrol™ Flu A and B inactivated controls for antigen-based assays.
Innovative Controls for Molecular Diagnostics: Development of Recombinant Phage-like Particles that Encapsulates Target RNA Viral Gene Segments
This poster explores how ZeptoMetrix developed a method to generate stable, recombinant phage-like particles that can be deployed to develop controls for emerging or highly pathogenic RNA viruses quickly.
PROtrol SARS CoV-2 Poster
Development of Inactivated SARS CoV-2 Control for Antigen-Based Assays
ZeptoMetrix Joint Infection Panel
Performance verification is a critical component of implementing a diagnostic test in a clinical lab and can be time consuming and costly. A verification protocol and organism panel were developed in collaboration with ZeptoMetrix ® to verify all analyte detections for the BioFire ® Joint Infection (JI) Panel*. The proposed BioFire Joint Infection Panel detects 31 potential pathogens and 8 potential antimicrobial resistance (AMR) genes associated with joint infections from synovial fluid specimens.